Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention (PREDICOP)
Primary Purpose
Breast Neoplasms, Recurrence
Status
Unknown status
Phase
Phase 3
Locations
Spain
Study Type
Interventional
Intervention
Diet
Physical activity
Minimal diet intervention
Minimal physical activity intervention
Sponsored by
About this trial
This is an interventional prevention trial for Breast Neoplasms focused on measuring Breast Neoplasms, Recurrence, Motor Activity, Diet, Quality of Life
Eligibility Criteria
Inclusion Criteria:
- incident primary breast cancer (ICD-O C50)
- stage at diagnosis I, II, IIIA (or T1-3, N0-N2, M0)
- age at diagnosis below 76 years
- within 3 months since completion of standard treatment (excluding hormonal therapy) and within 15 months since the diagnosis of the disease
Exclusion Criteria:
- morbid obesity (BMI >40kg/m²) or underweight (BMI <18kg/m²)
- ischemic heart disease (coronary syndrome, unstable angina or myocardial infarction) or cerebrovascular incident (ischemic or hemorrhagic) during the previous 12 months
- diabetes (only if unstable - glycosylated haemoglobin >9%)
- current medical or surgical treatment to lose weight
- mental illness that would prevent the patient from carrying out the intervention
- logistical factors which would prevent the patient from carrying out the intervention (distance to travel, work or family commitments)
- pregnant or planning pregnancy
Sites / Locations
- Fundació Institut d'Investigació Germans Trias i Pujol
- Institut Catala d'Oncologia - L'Hospitalet
- Consorci Sanitari de Terrassa
- Hospital Vall d'Hebron
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Intervention
Minimal intervention
Arm Description
Lifestyle intervention combining weight control, diet and physical activity
Minimal diet intervention and minimal physical activity intervention
Outcomes
Primary Outcome Measures
Time to local and distant recurrence
Time between recruitment date and local and distant recurrence date or end of the 5-year follow-up which ever occurs first
Secondary Outcome Measures
Overall survival
Time between recruitment date and death date or end of 5-year follow-up which ever occurs first
Disease free survival
Time between recruitment date and recurrence (local or distant) or death or end of 5-year follow-up which ever occurs first
Quality of life
Quality of life assessments using the SF36, the FACIT (fatigue questionnaire) and the HADS (Anxiety and depression)
Full Information
NCT ID
NCT02035631
First Posted
January 10, 2014
Last Updated
January 13, 2014
Sponsor
Institut Català d'Oncologia
1. Study Identification
Unique Protocol Identification Number
NCT02035631
Brief Title
Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention
Acronym
PREDICOP
Official Title
Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention
Study Type
Interventional
2. Study Status
Record Verification Date
January 2014
Overall Recruitment Status
Unknown status
Study Start Date
January 2014 (undefined)
Primary Completion Date
January 2022 (Anticipated)
Study Completion Date
January 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Català d'Oncologia
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main purpose of our study is to assess the effect of a lifestyle intervention combining weight control, diet and physical activity on the risk of recurrences among breast cancer patients with non-metastatic tumours in terms of 5-year cumulative incidence of recurences.
Detailed Description
BACKGROUND/MAIN OBJECTIVE: The main purpose of our study is to assess the effect of a lifestyle intervention combining weight control, diet and physical activity on the risk of recurrences among breast cancer patients with non-metastatic tumours. As secondary objectives we aim to assess whether the proposed intervention is able to improve the overall survival or the disease-free survival, as well as quality of life of breast cancer patients. METHODOLOGY: This multicentric randomized controlled trial aims to include 2108 women (1054 per arm), aged up to 75 years, diagnosed with a non-metastatic breast cancer (stage I, II, IIIA) in the participating centres, whose standard treatment was completed within the last 3 months. Participants will be assigned to either an intervention or a control group, and followed for five years. Patients assigned to the control arm will continue with the usual care, including standard guidelines for weight control applied in the centre. Patients in the intervention group will be involved in a lifestyle program with two components. The dietary part will aim to achieve a calorie reduction while maintaining nutritional quality; the physical activity part will include supervised sessions of moderate intensity. Data will be analyzed on an intention to treat basis using time-toevent analysis. HYPOTHESES: We expect a significant reduction in the 5-year cumulative incidence of recurrences (primary outcome) in the intervention group. Furthermore, as secondary outcomes, we expect a significant increase in overall survival and an improvement of quality of life of patients included in the intervention arm.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasms, Recurrence
Keywords
Breast Neoplasms, Recurrence, Motor Activity, Diet, Quality of Life
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Lifestyle intervention combining weight control, diet and physical activity
Arm Title
Minimal intervention
Arm Type
Sham Comparator
Arm Description
Minimal diet intervention and minimal physical activity intervention
Intervention Type
Behavioral
Intervention Name(s)
Diet
Intervention Description
The dietary component, aimed to reduce calorie intake according to individual requirements, will be structured in 1-hour weekly sessions led by trained nutritionists. Sessions will concentrate on teaching participants about food groups, the food pyramid and Mediterranean diet, how to chose, prepare and cook hypo-caloric meals.
Intervention Type
Behavioral
Intervention Name(s)
Physical activity
Intervention Description
The physical activity component will include two sessions per week led by trained physical activity monitors including aerobic exercise of high/moderate intensity, and instruction about the at-home exercise activities (3 more sessions).
Intervention Type
Behavioral
Intervention Name(s)
Minimal diet intervention
Intervention Description
Some basic diet recommendations
Intervention Type
Behavioral
Intervention Name(s)
Minimal physical activity intervention
Intervention Description
Some basic recommendations on physical activity
Primary Outcome Measure Information:
Title
Time to local and distant recurrence
Description
Time between recruitment date and local and distant recurrence date or end of the 5-year follow-up which ever occurs first
Time Frame
5 years from recruitment day
Secondary Outcome Measure Information:
Title
Overall survival
Description
Time between recruitment date and death date or end of 5-year follow-up which ever occurs first
Time Frame
5 years
Title
Disease free survival
Description
Time between recruitment date and recurrence (local or distant) or death or end of 5-year follow-up which ever occurs first
Time Frame
5 years
Title
Quality of life
Description
Quality of life assessments using the SF36, the FACIT (fatigue questionnaire) and the HADS (Anxiety and depression)
Time Frame
Baseline, one year and three years
Other Pre-specified Outcome Measures:
Title
Changes in biomarkers
Description
Biomarkers related to:
sex hormone profile,
dietary intake,
insulin resistance,
inflammation process
and any biomarker possibly related to the progression of the disease.
Time Frame
Baseline and one year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
incident primary breast cancer (ICD-O C50)
stage at diagnosis I, II, IIIA (or T1-3, N0-N2, M0)
age at diagnosis below 76 years
within 3 months since completion of standard treatment (excluding hormonal therapy) and within 15 months since the diagnosis of the disease
Exclusion Criteria:
morbid obesity (BMI >40kg/m²) or underweight (BMI <18kg/m²)
ischemic heart disease (coronary syndrome, unstable angina or myocardial infarction) or cerebrovascular incident (ischemic or hemorrhagic) during the previous 12 months
diabetes (only if unstable - glycosylated haemoglobin >9%)
current medical or surgical treatment to lose weight
mental illness that would prevent the patient from carrying out the intervention
logistical factors which would prevent the patient from carrying out the intervention (distance to travel, work or family commitments)
pregnant or planning pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Antonio Agudo, MD-PhD
Phone
+34 932607401
Email
a.agudo@iconcologia.net
First Name & Middle Initial & Last Name or Official Title & Degree
Noemie Travier, MSc
Phone
+34 932607401
Email
ntravier@iconcologia.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Beatriz Cirauqui Cirauqui, MD
Organizational Affiliation
Fundació Institut d'Investigació Germans Trias i Pujol
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sonia Del Barco Berron, MD
Organizational Affiliation
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Vanesa Ortega Cebrián, MD
Organizational Affiliation
Hospital Vall d'Hebron
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Maria Angeles Arcusa Lanza, MD
Organizational Affiliation
Consorci Sanitari de Terrassa
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antonio Agudo, MD
Organizational Affiliation
Institut Català d'Oncología - L'Hospitalet (ICO)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fundació Institut d'Investigació Germans Trias i Pujol
City
Badalona
State/Province
Barcelona
ZIP/Postal Code
08916
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Beatriz Cirauqui Cirauqui, MD
Phone
+34 934978925
Email
bcirauqui@iconcologia.net
First Name & Middle Initial & Last Name & Degree
Beatriz Cirauqui Cirauqui, MD
Facility Name
Institut Catala d'Oncologia - L'Hospitalet
City
L'Hospitalet de llobregat
State/Province
Barcelona
ZIP/Postal Code
08908
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antonio Agudo, MD
Phone
+34 932607401
Email
a.agudo@iconcologia.net
First Name & Middle Initial & Last Name & Degree
Antonio Agudo, MD
Facility Name
Consorci Sanitari de Terrassa
City
Terrassa
State/Province
Barcelona
ZIP/Postal Code
08227
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Angeles Arcusa Lanza, MD
Phone
+34 937003612
Email
aarcusa@cst.cat
First Name & Middle Initial & Last Name & Degree
Maria Angeles Arcusa Lanza, MD
Facility Name
Hospital Vall d'Hebron
City
Barcelona
ZIP/Postal Code
08035
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vanesa Ortega Cebrián, MD
Phone
+34 934894350
Email
vortega@vhebron.net
First Name & Middle Initial & Last Name & Degree
Vanesa Ortega Cebrián, MD
Facility Name
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
City
Girona
ZIP/Postal Code
17003
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sonia Del Barco Berron, MD
Phone
+34 972225834
Email
sdelbarco@iconcologia.net
First Name & Middle Initial & Last Name & Degree
Sonia Del Barco Berron, MD
12. IPD Sharing Statement
Learn more about this trial
Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention
We'll reach out to this number within 24 hrs